Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells

Overview of attention for article published in Cancer Immunology, Immunotherapy, May 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 85 Dimensions

Readers on

mendeley: 71 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ANTIBODIES BINDING CD40 AND USES THEREOF

Application WO-2021197335-A1

World Intellectual Property Organisation (WIPO)